Navigation Links
Jay Leno Puts EECP In National Spotlight With Monologue Joke
Date:1/15/2014

Los Angeles, California (PRWEB) January 15, 2014

Jay Leno put EECP® (Enhanced External Counterpulsation) by Global Cardio Care centers, the leaders in EECP treatment, in the national spotlight with a joke during his monologue Jan. 10, 2014. While Sara Soulati, CEO of Global Cardio Care, showcased the blood circulation machine called EECP with a patient on the bed, Leno described the machine as “a way to improve blood circulation; it looks dirty, but it’s not.”

Global Cardio Care and EECP were the featured topics on KTLA-TV (NBC-5) in Los Angeles Jan. 9, 2014. Global Cardio Care is the gold standard in EECP, and it launched in 2002. The company manages the world’s largest physician centers delivering EECP with 22 beds.

"EECP is one of the most powerful therapies to prevent and fight cardiovascular disease," said Sara Soulati, CEO and founder of Global Cardio Care, Inc. "When Jay Leno featured me showcasing EECP during his monologue, we took it for what it was -- a joke, a few laughs, and more national attention for EECP -- exactly what we need!"

What Is EECP

EECP is a circulation therapy that treats and prevents cardiovascular disease, stroke, diabetes, high blood pressure, chest pain, and many other diseases and illness.

When a patient receives the therapy, they lie on a comfortable bed hooked to a heart monitor. Three blood-pressure-type cuffs wrap around calves, thighs and buttocks. When the heart is at rest, the cuffs squeeze the lower extremities in rapid sequence.

When the cuffs squeeze:

  •     More nitric oxide is secreted within arterial walls that reduces arterial stiffness, reduces high blood pressure and improves cardiovascular disease.
  •     New arteries grow naturally with an increase in vascular endothelial growth factor. This hormone stimulates growth of new arteries called collaterals that improve circulation and blood flow around blockages, like a natural bypass.
  •     Organs regenerate due to EECP treatment. Regenerative therapy is the process of replacing or regenerating human cells and tissue to restore and establish normal function.

About Global Cardio Care

Global Cardio Care® Inc. was launched in 2002 by Sara Soulati, CEO and founder. She and her team manage physician practices that deliver EECP, a circulation therapy that regenerates all organs while growing new arteries (angiogenesis). With 22 beds operating in two centers in Los Angeles, Global Cardio Care is the leader and gold standard in management of the world’s largest independent physician EECP centers. To schedule a free EECP trial, contact 310-412-8181. Learn more at http://GlobalCardioCare.com and follow the company on Facebook, Twitter and Google+.

Read the full story at http://www.prweb.com/releases/GlobalCardioCare/EECP/prweb11489832.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. MU receives national award for using mind-body approach to improve health
2. International breast health global summit will focus on supportive care and quality of life
3. International conference to explore health of descendants of transatlantic slave trade
4. National poll: Low cost, lifesaving services missing from most older patients health care
5. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
6. Kessler Foundation researchers present at first International Congress on Cognition in MS
7. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
8. Georgetown physician leads national resveratrol study for Alzheimers disease
9. National initiative launched to change the way biology departments approach undergraduate education
10. Boston researcher, surgical oncologist receives national award
11. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: